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Summary 
Background: Massive weight loss can notably affect patients’ health-related quality of 
life (HRQoL) and body image. Yet, no body contouring speciﬁc instruments to assess HRQoL 
and body image after massive weight loss have been validated in Finnish. The BODY-Q includes 
26 independently functioning scales and a single checklist that measure appearance, HRQoL, 
and experience of care. The aim of the present study was to translate and validate a Finnish 
version of the BODY-Q among patients who underwent abdominoplasty. 
Methods: The BODY-Q was translated into Finnish using recommended guidelines. Eighty-two 
patients who underwent abdominoplasty due to massive weight loss were identiﬁed from hospi- 
tal records using procedure codes. A postal survey including the BODY-Q, the 15D, and general 
health and pain instruments was used. Criterion validity, Cronbach’s alpha, and ﬂoor and ceiling 
effects were analyzed. 
Results: The BODY-Q translated well into Finnish. Fifty-three patients returned the question- 
naires (response rate 65%) and were included. All but the Scars subscale correlated signiﬁcantly 
with the 15D mean score, thus indicating strong criterion validity against a generic HRQoL tool. 
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The Excess Skin and the Physical Function scales reached the ceiling effect ( > 15% of maximum 
points) in our postoperative sample. No ﬂoor effects were observed. Internal consistency of the 
BODY-Q scales was high (Cronbach’s alpha range, 0.81–0.95). 
Conclusions: The Finnish version of the BODY-Q instrument is equivalent in terms of content, 
accuracy, and comprehensiveness to the original English version. The ﬁndings of the present 
study indicate that the BODY-Q has psychometric properties suitable for assessing outcomes 
and treatment effectiveness of abdominoplasty. 
© 2019 British Association of Plastic, Reconstructive and Aesthetic Surgeons. Published by El- 
sevier Ltd. All rights reserved. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
further contact was made. Introduction 
Excess skin after weight loss has a notable impact on
appearance and health-related quality of life (HRQoL). 1 
Therefore, body contouring surgery for esthetic and health-
promoting purposes after bariatric surgery and massive
weight loss can signiﬁcantly improve patients’ body image
and HRQoL. 2–6 
In Finland, the single-payer public healthcare currently
provides body contouring for patients whose condition of
excess skin requires recurring health services. 7 Indications
for operation can be intertrigo, limitations in daily activ-
ities, or restrictions in physical activities due to excess
skin. 7 An additional criterion is body mass index (BMI) less
than 32 kg/m. 7 Body contouring for purely esthetic reasons
is not funded by the public healthcare system, but the
patient can seek help from the private sector. There are no
data available of the amount of body contouring procedures
performed annually in Finland or Europe. Although several
international studies have shown body contouring surgery
for excess skin to have a positive impact on HRQoL and body
image, the evidence to support these procedures in Finnish
patients is scarce. 2,3 Furthermore, generic patient-reported
outcome (PRO) HRQoL instruments may not be speciﬁc
enough to capture what is relevant to patients with excess
skin. 
The BODY-Q was designed to capture what is most rel-
evant for patients undergoing weight loss and/or body con-
touring. 8 The original BODY-Q ﬁeld-test publication included
18 scales and the obesity-speciﬁc symptom checklist. 8 More
recently, the BODY-Q © has added a Chest Module (chest and
nipples scales) ﬁeld-tested in 689 participants 9 and a stretch
marks scale tested with 630 participants. 10 The BODY-Q
scales and checklist measure appearance ( n = 12), HRQoL
( n = 6), and experience of health care ( n = 4). 8 
The BODY-Q instrument has extensive potential for as-
sessing different aspects of the impact of body contouring
surgery. Nonetheless, to the best of our knowledge, the only
foreign language (other than American and British English)
validation study of the BODY-Q to date has been that of
Poulsen and her team in Danish. 11 There has been a need for
a weight loss and body contouring-speciﬁc PRO instrument
in Finnish to assess the effectiveness of procedures such as
abdominoplasty after massive weight loss to further clarify
the importance for these operations in the Finnish public
health care system. 
The BODY-Q was chosen for linguistic and psycho-
metric validation into Finnish because of its reliability,
validity, and responsiveness. 1,8 , 11–13 More speciﬁcally, thePlease cite this article as: J.P. Repo, P. Homsy and M.M. Uimonen et al.
outcome instrument among patients who underwent abdominoplasty, Jo
org/10.1016/j.bjps.2019.02.017 BODY-Q has undergone a rigorous development process
that included 63 patient interviews, 22 cognitive inter-
views, and input from 9 clinical experts, followed by an
international (Canada, USA, and UK) ﬁeld-test study that
included 403 pre- and postweight loss and 331 pre- and
postbody contouring surgery patients. 8 A recent systematic
review that compared 24 PRO instruments for bariatric
and body contouring surgery singled out the BODY-Q as
possessing the strongest evidence for quality of measure-
ment properties. 12 As it can be used to capture what is
relevant to the patient, it was recommended to be used
in future clinical trials 12 for assessing the HRQoL and
body image related to excess skin after massive weight
loss. 
The aim of the present study was to investigate the re-
liability and validity of the Finnish version of the BODY-Q ©
instrument among patients who had undergone abdomino-
plasty. 
Methods 
The study protocol was approved by the Ethics Commit-
tee of Helsinki and Uusimaa Hospital District and the head
of the Musculoskeletal and Plastic Surgery Research Cen-
ter, Helsinki, Finland. Patients who had undergone ab-
dominoplasty from 2009 to 2017 were identiﬁed from hospi-
tal records using the Nordic Medico-Statistical Committee
(NOMESCO) procedure code QBJ30 Correction of Abdom-
inal Apron . Inclusion criteria were complete understand-
ing of written Finnish, age at least 18 years, and previous
abdominoplasty procedure due to massive weight loss. Pa-
tients who underwent abdominoplasty postpregnancy or due
to hernia were excluded. Altogether, 82 matching massive
weight loss patients were identiﬁed from hospital records. 
Patients were approached through mail by sending a
questionnaire package that included the BODY-Q, the 15D,
visual analog scale to measure pain and general health, and
clinical and demographic questions. Patient records were
reviewed for the indication of the body contouring pro-
cedure, the amount of weight loss before the operation,
whether the patient had undergone bariatric surgery be-
fore the body contouring, date of the body contouring pro-
cedure, and age and sex of the participants. Participants
signed an informed consent according to the Declaration
of Helsinki and returned the completed questionnaires to-
gether with the signed consent in a prepaid envelope. No, Validation of the Finnish version of the BODY-Q patient-reported 
urnal of Plastic, Reconstructive & Aesthetic Surgery, https://doi. 
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ODY-Q ©
he original BODY-Q set of 18 scales and obesity-speciﬁc 
ymptom checklist, which measure appearance ( n = 9), 
RQoL ( n = 5), and patient experience of care ( n = 4), was
sed. The Appearance scales assess satisfaction with dif- 
erent parts of the body (Abdomen, Arms, Back, Body, But-
ocks, Inner thighs, or Hips and Outer Thighs) as well as how
othered someone is with Excess Skin and body contouring 
cars. The HRQoL scales measure Body image, Physical func- 
ioning, Physical symptoms, Psychological functioning, Sex- 
al functioning, and Social functioning. Patient experience 
easures Doctor/Surgeon, Information, Medical team, and 
fﬁce staff. 
The BODY-Q scales function independently, and it is 
ecommended that only relevant scales are used depending 
n the patient population and/or research question being 
sked. Because the focus of our study was on abdomino-
lasty, participants were asked to complete the Abdomen, 
cars, and Excess skin appearance scales alongside all 
RQoL scales, which best serve for abdominoplasty pa- 
ients. The BODY-Q scores can be converted to a scale from
 to 100. 
5D instrument 
he 15D is a valid and reliable, generic self-administered 
RQoL instrument containing the following 15 dimensions: 
oving, Seeing, Hearing, Breathing, Sleeping, Eating, 
peech, Excretion, Usual activities, Mental function, Dis- 
omfort and symptoms, Depression, Distress, Vitality, and 
exual activity. 14 Patients choose one of the ﬁve levels in 
ach dimension that best describes their current state of 
ealth (1–5; best to worst possible score). This study used 
he 15D single index score, which represents the overall 
RQoL. The score ranges from 0 to 1, with 0 equivalent
o being dead and 1 being the best imaginable HRQoL 
tate. The 15D was chosen for criterion validity testing of
he Finnish version of the BODY-Q, as the 15D instrument
s a widely adopted instrument in Finland, 15 and it has 
reviously been used to assess the treatment effectiveness 
f excess skin using abdominoplasty procedure in Finnish 
atients. 2,3 
ociodemographic and clinical data questionnaire 
nformation of participants’ height, weight, occupational 
etails, smoking, and alcohol consumption habits was ob- 
ained. A visual analog scale ranging from 0 to 100 mm (0–
00 mm; best to worst) was used to measure participants’
elf-reported general health and pain intensity during the 
receding week. 
ranslation and cross-cultural adaptation 
he linguistic validation of the 18 BODY-Q scales and check- 
ist adhered to the International Society for Pharmacoeco- 
omics and Outcomes Research (ISPOR) guidelines. 16 The 
SPOR translation process is described in more detail else- 
here. 16 Two separate certiﬁed, professional native Finnish 
ranslators produced two forward-translations leading to 
 reconciliation version of these two versions. A profes- 
ional native English translator ﬂuent in Finnish and familiar 
ith the Finnish culture produced a back-translation of the Please cite this article as: J.P. Repo, P. Homsy and M.M. Uimonen et al.
outcome instrument among patients who underwent abdominoplasty, Jo
org/10.1016/j.bjps.2019.02.017 innish version 1. A back-translation panel and a steering
roup of three surgeons assessed the whole process on sep-
rate occasions. Five patients participated in pilot-testing 
he proposed Finnish version and were later interviewed to
eveal any discrepancies in the questionnaire. Pretesting of 
he instrument with ﬁve patients was done by adhering to
he ISPOR guidelines. 16 These ﬁve patients completed each 
f the scales. The committee assessed the pretesting and
ognitive debrieﬁng outcomes. A linguistic expert proofread 
he ﬁnal version. 
tatistical analysis 
linical, sosiodemographic, and PRO instrument data are 
resented as mean with standard deviation (SD), 95% con-
dence intervals (95% CI), or as numbers with percentages.
he BODY-Q scale scores were converted into 0–100 scores, 
ith higher scores indicating a better outcome. Normality of
he data for BODY-Q scales was assessed. Missing values for
ingle variables were imputed adhering to the mean value
f other items in the subscale. 
Scale targeting was investigated calculating the ﬂoor 
nd ceiling values (precentage of minimun and maximum 
oints). A ﬂoor or ceiling effect was considered to be con-
rmed if 15% of patients scored minimum or maximum
oints. 17 Cronbach’s alpha served for assessing internal con- 
istency for the BODY-Q subscales. 
Linearity with the 15D was assessed to reveal the rela-
ionships between the most relevant subscales for patients 
ho underwent abdominoplasty. The authors hypothesized 
hat the generic HRQoL would have a robust linear relation-
hip with BODY-Q subscales of interest. 
Spearman correlation coefﬁent was used to identify cor- 
elation between the 15D mean score and the subscales of
he BODY-Q. Bootstrap method with 5000 replications was 
sed to obtain 95% CIs. The authors hypothesized that there
ould be a > 0.50 correlation between the Abdomen scale
nd the 15D scores. The information of the strongest corre-
ation with each of the BODY-Q scales was used to choose
he appropriate reference measure for criterion validity as- 
essment with the Spearman correlation. 
Furthermore, linear regression analyses were used to 
dentify the appropriate predictors of the BODY-Q standard- 
zed by age, postoperative BMI, and gender. The regression
oefﬁcient β-value showed how strongly each predictor 
ariable inﬂuenceed the criterion variable. The authors 
easured the β-value in units of SD. Cohen reference
alues are 0.1, 0.3, and 0.5 for small, moderate, and strong
orrelations, respectively. 
Analyses were performed using SPSS 25.0 and R. Results 
re reported adhering to the COSMIN guidelines. 18 
esults 
ranslation and adaptation 
he BODY-Q translated well into Finnish. The back- 
ranslation revealed minor linguistic differences in some 
djectives compared to the original English version. 
he differences were addressed and discussed with the 
uestionnaire developer. A translation review panel and 
 steering group of three surgeons who were ﬂuent in, Validation of the Finnish version of the BODY-Q patient-reported 
urnal of Plastic, Reconstructive & Aesthetic Surgery, https://doi. 
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Table 1 Patients’ sociodemographic and clinical details. 
N = 53 
Age, years (SD) 48.8 (12.4) 
Women, n (%) 45 (84.9) 
BMI before operation, mean (SD) 31.2 (6.2) 
Indication for operation, n (%) 
Excess skin, esthetic 47 (88.7) 
Weight loss 32 (60.4) 
Postbariatric 15 (28.3) 
Hygienic problems or eczema due 
to excess skin 
6 (11.3) 
15D score, mean (SD) 0.88 (0.09) 
BODY-Q and other scales, mean (SD) 
Arms 48.1 (27.9) 
Back 52.4 (27.8) 
Body 46.6 (16.4) 
Buttocks 62.3 (25.6) 
Inner thighs 51.1 (36.6) 
Hips and outer thighs 49.0 (24.2) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 Finnish and English each reviewed the different versions
of the translations and minor adjustments were made.
The pilot-testing and cognitive debrieﬁng interviews with
ﬁve patients indicated good external validity. Speciﬁcally,
patients described the Finnish version of the BODY-Q as
understandable and easy to complete. The pilot-testing and
interviews did not lead to changes. No further adjustments
were required, and the ﬁnal version was completed with
due proofreading by a linguistic expert. 
Patients 
Fifty-three patients returned the questionnaires and were
included in the analysis. Response rate was 65%. Mean (SD)
weight loss before abdominoplasty was 48.3 (15.9) kg. Al-
together, 45 (85%) patients were women. Indication for op-
eration was excess skin due to massive weight loss ( n = 47)
or hygienic problems or eczhema due to excess skin after
weight loss ( n = 6). Patients’ sociodemographic and clinical
data and other BODY-Q Appearance scale scores unrelated
to abdominoplasty are presented in Table 1 . Table 2 Mean BODY-Q scores of postoperative patients, Cronbach
Category Mean (SD) Alpha (95
Abdomen 51.6 (25.1) 0.95 (0.9
Scars 78.4 (24.3) 0.95 (0.9
Excess skin 51.5 (31.2) 0.95 (0.9
Body image 36.9 (25.1) 0.94 (0.9
Physical function 80.6 (22.8) 0.91 (0.8
Psychological 66.2 (24.2) 0.95 (0.9
Sexual 48.9 (25.7) 0.81 (0.6
Social 67.9 (22.2) 0.94 (0.9
Physical symptoms 66.3 (19.6) 0.86 (0.7
Please cite this article as: J.P. Repo, P. Homsy and M.M. Uimonen et al.
outcome instrument among patients who underwent abdominoplasty, Jo
org/10.1016/j.bjps.2019.02.017 Internal consistency 
Cronbach’s alpha (CI 95%) exceeded 0.90 in all but one sub-
scale as in physical symptoms subscale, the alpha was 0.87
(0.82–0.91). The Cronbach alpha values indicated excellent
internal consistency in all but Physical symptoms subscale,
in which the consistency was still good ( Table 2 ). 
Criterion validity 
Results of Spearman correlation matrix of BODY-Q subscales
with bootstrapped 95% CIs and the 15D mean score and Men-
tal health score are presented in Table 3 . All BODY-Q sub-
scales, with the exception of the Scars scale, correlated sig-
niﬁcantly with the 15D score ( Figure 2 ). Spearman correla-
tion coefﬁcients of 15D and Abdomen, Body image, Physical
function, and Psychological subscales exceeded 0.5, indi-
cating moderate to strong correlation. Additionally, corre-
lations between the 15D mean score and Abdomen, Excess
skin, and Social subscales were weak to moderate. The Scars
subscale did not correlate with the 15D score. Only the So-
cial subscale correlated signiﬁcantly with the 15D dimension
of Mental health. 
The 15D mean score had a very strong relationship with
BODY-Q scale of physical symptoms as revealed by the β
value. All relationships of the BODY-Q subscales and the 15D
are presented in Figure 3 . 
Normality of the data 
In the subscales of Scars and Physical function, the dis-
tribution was skewed to the right with higher scores. The
distribution of scores in the Appearance of abdomen and
Appearance of excess skin subscales was bimodal ( Figure 1 ).
Floor and ceiling effect 
In the Scars, Physical function, Psychological, and Social
subscales, none of the patients received the lowest score,
and in the Abdomen, Excess skin, and Body image subscales,
the percentage of minimum values was low: 3.8, 7.5, and
7.5, respectively ( Table 2 ). Some of the patients scored the
maximum in every subscale. Ceiling values were found in
Physical function and Scars subscales with percentages of
32.7 and 36.5, respectively ( Table 2 ). ’s alphas, and percentage of maximum and minimum points. 
% CI) Maximum (%) Minimum (%) 
3–0.97) 3.8 3.8 
2–0.97) 36.5 0.0 
1–0.97) 7.5 7.5 
1–0.96) 0.0 7.5 
5–0.94) 32.7 0.0 
2–0.97) 5.8 0.0 
8–0.89) 5.9 5.9 
0–0.96) 9.4 0.0 
9–0.90) 1.9 0.0 
, Validation of the Finnish version of the BODY-Q patient-reported 
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Table 3 Spearman correlations with bootstrapped 95% CIs of BODY-Q subscale scores, 15D score, and mental health dimension 
score. 
r (95% CI) 15D score 15D Mental health 
Abdomen 0.549 (0.299–0.754) ∗∗ −0.187 ( −0.419–0.072) 
Scars 0.342 (0.064–0.571) ∗ −0.231 ( −0.490–0.066) 
Excess skin 0.452 (0.212–0.666) ∗∗ −0.350 ( −0.565 to −0.134) ∗
Body image 0.663 (0.438–0.821) ∗∗ −0.336 ( −0.528 to −0.115) ∗
Physical function 0.654 (0.435–0.803) ∗∗ −0.051 ( −0.305–0.186) 
Psychological 0.662 (0.420–0.814) ∗∗ −0.237 ( −0.461 to −0.029) 
Sexual 0.319 (0.040–0.564) ∗ −0.219 ( −0.477–0.058) 
Social 0.530 (0.242–0.735) ∗∗ −0.316 ( −0.524 to −0.069) ∗
Physical symptoms 0.495 (0.217–0.704) ∗∗ 0.072 ( −0.214–0.349) 
∗ p -value < 0.05. 
∗∗ p -value < 0.01. 
Figure 1 Distribution of scores for the selected BODY-Q subscales. The line illustrates a normal distribution. On the Y -axis, the 
values refer to relative frequency, and on the X -axis, the scores of the subscale are presented. 
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iiscussion 
he BODY-Q translated well into Finnish. The present study 
uggests that the Finnish version of the BODY-Q can provide
alid scores for assessing outcomes after abdominoplasty 
ue to massive weight loss. Some ceiling effect was noted
n the subscales of Physical function and Scars, indicating 
otential problems in the content validity in assessing the 
ong-term outcomes in this population ( Figure 1 ). Please cite this article as: J.P. Repo, P. Homsy and M.M. Uimonen et al.
outcome instrument among patients who underwent abdominoplasty, Jo
org/10.1016/j.bjps.2019.02.017 There was a need for a speciﬁc instrument for massive
eight loss and body contouring surgery in the Finnish lan-
uage. The BODY-Q was chosen for translation and quanti-
ative psychometric testing, as it has proven to be reliable,
alid, and have responsive qualities, which are considered 
he most essential ones for a PRO instrument to be psycho-
etrically sound. 
The present linguistic validation study of the BODY-Q 
nstrument showed no disease-speciﬁc, health-related, or , Validation of the Finnish version of the BODY-Q patient-reported 
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Figure 2 Linearity between the 15D score and each of the BODY-Q subscales. The gray area shows 95% CIs. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 cultural differences between the original and the translated
Finnish version of the BODY-Q. Mainly minor linguistic and
grammatical changes were needed in the process of transla-
tion. Every new instrument should undergo a translatability
assessment to reveal any problems in the item content
when applied to other languages. 19 Based on the ﬁndings
presented here, the BODY-Q had good translatability into
a non-Anglo-Saxon language. Thus, the Finnish version of
the BODY-Q instrument can be considered equivalent in
terms of content, accuracy, and comprehensiveness to the
original English version of the BODY-Q. 
The BODY-Q provides a set of scales focusing on topics
that are relevant to massive weight loss and body contour-
ing patients. Speciﬁc issues in massive weight loss and body
contouring surgery may not be covered in generic HRQoL
instruments, which tend to overlook appearance and body
image issues. As the present study used only the 15D instru-
ment, the results are not directly comparable to results of
other generic HRQoL instruments, such as the Short Form-36
and the EQ-5D, which are often used in bariatric research. 20 
The BODY-Q scales provided good coverage and targeting
in this study for patients who underwent abdominoplasty.Please cite this article as: J.P. Repo, P. Homsy and M.M. Uimonen et al.
outcome instrument among patients who underwent abdominoplasty, Jo
org/10.1016/j.bjps.2019.02.017 The distribution of scores was good in seven of the nine sub-
scales, which were chosen for their relevance in abdomino-
plasty. Two subscales (Excess skin and Physical function) ex-
ceeded the ceiling effect threshold. This is probably due to
the nature of the study design, as the patients were studied
postoperatively after having lost considerable weight. They
also underwent abdominoplasty to remove excess skin and
were not that bothered by excess skin after the procedure.
Speciﬁcally, there would likely not have been this many
maximum points in the Excess Skin scale if the patients had
completed the questionnaire before the operation as the
ﬁndings of Poulsen et al. 21 suggest. The function of these pa-
tients might have also been lower before the operation, as
one of the indications in Finland for abdominoplasty is limi-
tation in daily activities and physical activities. On the basis
of the ﬁndings, these patients had relatively good physical
function at the time of completing the questionnaires. 
In the present study, Cronbach’s alpha ranged between
0.87 and 0.96. The slightly lower Cronbach’s alpha values
are probably due to the speciﬁc patient selection. Nonethe-
less, the outcomes can be considered to be in line with those
reported in previous studies, thus indicating high internal, Validation of the Finnish version of the BODY-Q patient-reported 
urnal of Plastic, Reconstructive & Aesthetic Surgery, https://doi. 
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Figure 3 Predictors of the 15D for age-adjusted, BMI- 
adjusted, and gender-adjusted regression coefﬁcients β. Val- 
ues of ( ±) 0.10, 0.30, and 0.50 represent small, moderate, and 
large relationships, respectively. The boxplot indicates mean β, 
and the whiskers indicate 95% conﬁdence intervals. 
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 onsistency. The English versions of the BODY-Q subscales 
ad a Cronbach’s alpha (internal consistency) ranging from 
.90 to 0.98 among a heterogeneous population of weight 
oss patients and body contouring patients. Poulsen et al. 
lso found similar internal consistency in their psychomet- 
ic study of the BODY-Q. 9 On the basis of these results, it
ould seem that the items in each of the scales are closely
elated. 
The present psychometric analysis further investigated 
he criterion validity of the BODY-Q among a speciﬁc ab-
ominoplasty sample. The results showed that the generic 
RQoL had statistically signiﬁcant correlation with most of 
he BODY-Q subscales investigated in the present study. Lin- 
arity illustrations were in line with these results. On the
asis of these results, the BODY-Q subscales seem to reﬂect
ell patients’ HRQoL. The BODY-Q has previously been vali- 
ated among a representative population of massive weight 
oss and body contouring patients. This study further vai- 
ated the instrument for assessing outcomes in abdomino- 
lasty patients. 
The Finnish version of the BODY-Q can be used for
ealth care quality controls and charting patients’ current 
r changing HRQoL and body image status. Future prospects 
ill include longitudinal follow-up data collection from pa- 
ients undergoing body contouring surgery. In addition to 
he data presented here, the BODY-Q Chest Module 9 has 
ecently been introduced, and it has been translated and 
dapted into Finnish. 22 Validation of the Finnish version of 
he BODY-Q instrument allows participation in the BODY-Q 
etwork, with an aim to evaluate the effectiveness of body 
ontouring surgery as a multinational, multicenter joint 
enture. 
To the best of our knowledge, the present study is the
rst to evaluate the criterion validity of the BODY-Q instru-
ent. An additional strength of our study is that the authors
alidated the BODY-Q for a speciﬁc group of patients provid-
ng valuable information about the measurement properties 
f the BODY-Q among patients who underwent abdomino- 
lasty. This information can be further used when analyzing 
uture data obtained from patients after abdominoplasty. Please cite this article as: J.P. Repo, P. Homsy and M.M. Uimonen et al.
outcome instrument among patients who underwent abdominoplasty, Jo
org/10.1016/j.bjps.2019.02.017 he somewhat small sample size can still be considered
ufﬁcient for psychometric analyses. 17 A larger sample size 
ould have, however, allowed to use the Rasch analysis or
tem response theory to further investigate the psychome- 
ric properties of the BODY-Q among this particular patient
ample. Furthermore, the present study did not assess the
est-retest reliability or responsiveness of the Finnish ver- 
ion of the BODY-Q instrument. The use of the SF-36 or the
WQoL Lite insruments could have provided further insight 
f the criterion validity of the BODY-Q among abdomino-
lasty patients. 
onclusions 
he translation of the Finnish version of the BODY-Q 
ollowed robust translation and cross-cultural adaptation 
uidelines. Translatability of the BODY-Q into Finnish was 
ood, as only minor adjustments were needed during the
ranslation process. The Finnish version of the BODY-Q 
roved to have good internal consistency and strong crite-
ion validity with generic HRQoL. Some ceiling effect was 
oted in the subscales of Physical funtion and Scars. The
omprehensive BODY-Q seems to be a useful tool for as-
essing appearance, HRQoL, and patient experience after 
eight loss in patients who underwent abdominoplasty. 
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